MEREO BIOPHARMA (MREO)
(Delayed Data from NSDQ)
$3.42 USD
-0.02 (-0.58%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $3.44 +0.02 (0.58%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/21/24 |
---|---|
Current Quarter | -0.01 |
EPS Last Quarter | -0.01 |
Last EPS Surprise | NA |
ABR | 1.25 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.03 |
Next Year | 0.03 |
EPS (TTM) | NA |
P/E (F1) | 114.67 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 100.00M | 60.00M |
# of Estimates | NA | NA | 1 | 1 |
High Estimate | NA | NA | 100.00M | 60.00M |
Low Estimate | NA | NA | 100.00M | 60.00M |
Year ago Sales | NA | NA | 10.00M | 100.00M |
Year over Year Growth Est. | NA | NA | 900.00% | -40.00% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.01 | -0.01 | 0.03 | 0.03 |
# of Estimates | 1 | 1 | 2 | 1 |
Most Recent Consensus | -0.01 | -0.01 | -0.06 | 0.03 |
High Estimate | -0.01 | -0.01 | 0.12 | 0.03 |
Low Estimate | -0.01 | -0.01 | -0.06 | 0.03 |
Year ago EPS | NA | NA | -0.20 | 0.03 |
Year over Year Growth Est. | NA | NA | 115.00% | 0.00% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.01 | -0.01 | 0.03 | 0.03 |
7 Days Ago | -0.01 | -0.01 | 0.03 | 0.03 |
30 Days Ago | NA | NA | 0.03 | 0.00 |
60 Days Ago | NA | NA | 0.02 | 0.00 |
90 Days Ago | NA | NA | 0.02 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.01 | -0.01 | 0.03 | 0.03 |
Zacks Consensus Estimate | -0.01 | -0.01 | 0.03 | 0.03 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.01 | NA | NA | NA | NA |
Estimate | NA | NA | NA | NA | NA |
Difference | NA | NA | NA | NA | NA |
Surprise | NA | NA | NA | NA | NA |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more